UHPLC-Q-TOF MS-Based Profiling of Cell Culture Medium and Post-Culture Supernatant Combined with a Retention Time-Integrated Database

Significance of the topic

Cell culture medium composition is a primary determinant of in vitro cell behavior and performance. Comprehensive characterization of medium components and the metabolites produced by cultured cells is essential for quality assurance, formulation optimization, cost control, troubleshooting and for improving consistency and yield in biopharmaceutical production and cell therapies. Integrating chromatographic retention-time information with high-resolution mass spectrometry enhances confidence in compound identification, supports isomer separation and improves analysis of challenging analytes such as phosphate-containing metabolites.

Objectives and study overview

This study developed an UHPLC-Q-TOF MS workflow combined with a retention time–integrated personal compound database library (PCDL) to profile components of cell culture media and post-culture supernatants. Goals were to (1) build a retention-time-enabled library for common nutrients and central carbon pathway metabolites, (2) validate chromatographic separation (including isomers and phosphate-containing compounds), and (3) compare metabolic signatures between two media/supernatant pairs (labelled 1-1 and 6-4) to illustrate how medium formulation affects cellular metabolism and potential product-relevant pathways (e.g., glycosylation precursors).

Methodology

Sample preparation: Four samples (two raw media: 1-1-M, 6-4-M; two post-culture supernatants: 1-1-S, 6-4-S) were diluted with 80% acetonitrile/water, centrifuged and the clarified supernatants analyzed by UHPLC-Q-TOF MS.

Chromatography and mass spectrometry strategy: Hydrophilic interaction liquid chromatography (HILIC) was used to retain polar nutrients and central carbon metabolites, coupled to a Q-TOF for high-resolution MS detection with both positive and negative ion modes to maximize coverage. A retention time–enabled PCDL (>220 compounds) supported targeted confirmation across amino acids, vitamins/coenzymes, sugars, amines and key metabolites from glycolysis, pentose phosphate pathway (PPP) and TCA cycle.

Data processing: Agilent MassHunter Profinder B.10 was used for component analysis and library matching. Retention time matching was emphasized to resolve isomeric peaks and to flag in-source fragments that could otherwise cause misidentification.

Used instrumentation

Key instrumentation and operational highlights used in this study:

• UHPLC: Agilent Infinity III system operated in HILIC mode for polar metabolites.
• Mass spectrometer: Agilent Q-TOF (Revident front-end described) acquiring positive and negative electrospray ionization data.
• Ion source and gases: AJS source; gas temperature ~300 °C; drying gas flow ~8 L/min; nebulizer ~0.3 mL/min; sheath gas temperature ~325 °C; sheath gas flow ~11 mL/min.
• Ion optics and voltages: capillary/ Vcap ≈ 3500 V; fragmentor ≈ 110 V; nozzle voltages noted at 500 V (positive) and 1000 V (negative).
• Library and software: Retention-time-indexed PCDL with >220 entries; Agilent MassHunter Profinder B.10 for feature extraction and matching.

Main results and discussion

Medium composition:

• Identified 21 amino acids in media samples, including all eight essential amino acids and a full complement of non-essential amino acids. Chromatography successfully separated isomeric leucine and isoleucine.
• Detected 14 vitamins and coenzymes (examples: riboflavin, nicotinamide, NAD+, FAD, PLP/PMP), three major sugar types (glucose, pentose, sucrose) and organic amines such as ethanolamine/monoethanolamine, diethanolamine and trimethylamine.
• Comparative media profiling showed that medium 1-1 contained higher overall levels of amino acids, vitamins, sugars and amines than 6-4, with a relatively larger proportion of essential amino acids and organic amines in 1-1.

Cell supernatant/metabolites:

• A total of 99 metabolites were detected in supernatants and classified across multiple functional groups: essential/non-essential amino acids, amino-acid metabolites, vitamins/coenzymes, glycolysis and PPP intermediates, TCA cycle metabolites, energy metabolites, nucleosides/bases and sugars.
• Retention time information proved critical to avoid misidentification: for example, two peaks at the nominal fumarate m/z were resolved by RT and standards showed the later peak was an in‑source fragment of malate.
• Phosphate-containing metabolites, which commonly produce poor peak shapes, were well resolved in this method — UMP is shown as an example of improved chromatographic behavior, increasing confidence and quantitative reliability for energy-related metabolites.

Comparative metabolic phenotypes between 1-1 and 6-4 supernatants:

• Sample 1-1 demonstrated a metabolically active phenotype with strong upregulation of pyrimidine metabolism (e.g., dU ~70-fold, cytosine ~43-fold) and marked elevation of TCA cycle intermediates (citrate ~68-fold), suggesting heightened nucleotide biosynthesis and energy metabolism. Glycolysis/PPP and amino-acid pathways were also elevated.
• Sample 6-4 showed distinct activation of purine metabolism (inosine ~6.3-fold, cAMP ~3.1-fold), elevated glycolysis/gluconeogenesis markers (PEP ~4.4-fold), higher aspartate, and increased biotin (~5-fold). TCA cycle activation was more moderate in 6-4 (e.g., malate ~2.96-fold).
• UDP-glucose (UDP-Glc) was significantly higher in 6-4 supernatant; since UDP-Glc is a precursor in glycosylation, this observation may relate to differences in glycosylation potential relevant to antibody production.

Benefits and practical applications of the method

This retention time–integrated UHPLC-Q-TOF workflow provides several practical advantages:

• Improved identification confidence by combining accurate mass and RT matching, aiding separation of isomers and exclusion of in-source artifacts.
• Reliable profiling of phosphate-rich metabolites with better peak shapes, improving sensitivity and quantitative potential for energy metabolism studies.
• Comprehensive coverage of nutrients and central carbon metabolism allows correlation of medium formulation with cell metabolic state, supporting rational medium optimization and troubleshooting.
• Potential direct application to bioprocess development: metabolite markers (e.g., UDP-Glc) can inform strategies to optimize glycosylation and product quality for antibody therapeutics.

Future trends and potential uses

Potential extensions and developments inspired by this work include:

• Integrating metabolomics with antibody titer and product-quality metrics to derive correlations between medium composition, cellular metabolism and bioproduct yield/quality for data-driven process optimization.
• Expanding retention time–indexed libraries to include isotope-labelled standards and cell-line–specific metabolites for improved quantification and flux analysis.
• Adopting targeted quantification workflows for key pathway markers (nucleotides, UDP-sugars, TCA intermediates) to support routine QC in media manufacturing and bioprocess monitoring.
• Combining metabolomics with proteomics and single-cell approaches, as well as leveraging machine learning to predict medium formulations that drive desired phenotypes.
• Implementing online or automated sampling coupled to rapid UHPLC-MS to enable real-time metabolic monitoring during culture runs.

Conclusions

The study demonstrates that an RT-anchored UHPLC-Q-TOF approach with a >220-entry PCDL can robustly profile media components and cell-secreted metabolites, resolve isomers and reduce misidentifications from in-source fragments, and improve chromatography of phosphate-containing analytes. Distinct metabolic phenotypes between media formulations (1-1 vs 6-4) were identified, with implications for energy metabolism, nucleotide biosynthesis and glycosylation-relevant pathways. Incorporating metabolomics into bioprocess development promises more rational medium design and improved biotherapeutic production outcomes when combined with product measurements.

References

The content summarized here is based on the poster: Minghui Sun, Jia Tu, Yue Song, Jimmy Chan. UHPLC-Q-TOF MS-Based Profiling of Cell Culture Medium and Post-Culture Supernatant Combined with a Retention Time-Integrated Database. ASMS 2026, TP 249. Agilent Technologies Inc., Shanghai, China. Agilent publication RA260511.725, published June 30, 2026.